Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion...
Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...
Pfizer has announced plans to invest more than €1.2 billion at its site in Grange Castle, Dublin, Ireland, to double capacity for biological drug substances.
04.08.2017
- French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...
08.09.2016
- Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
29.03.2016
- French drug maker Sanofi has appointed Dr. Yong-Jun Liu, one of the world's most prolific researchers in immunology, as Head of Research, Global R&D, effective April 1, 2016. Dr...
09.03.2016
- US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...
